2022 Industry Programme
Location: Industry Room
09:00 – 10:00: NHS Main Plenary
10:00 – 11:00: MedTech and Diagnostics Regulation and Innovation – Regulation update
Chair – Andrew Davidson, MediWales Director
Medical Devices and Diagnostics. With IMDRF on the horizon as well as the MHRA looking to participate this will be a valuable forward looking discussion. MHRA/ABHI session
British Invitro Diagnostics Association – Ashleigh Batchen, Regulatory Affairs
Accelerating Innovation Through Regulation – Element Materials Technology – Micheal Kipping, Director, Medical Technologies EMEAA
11:00 – 11:30: BREAK
11:30 – 13:30: Finance, Funding and Business Support
Chair – Welsh Government
Development Bank Wales – Richard Thompson, Senior Investment Executive
Innovate UK – Dr David Cunnah, National Manager for Wales
Mercia Asset Mangement – Rafael Joseph, Investment Manager
Company case studies – IQ Endoscope – Matt Ginn, CEO and Ceryx Medical – Stuart Plant, CEO
Welsh Government support including International Trade (Medica/Arab Health/Bio Convention US) and Business support for companies
13:30 – 14:30: Lunch, Exhibition and Networking
14:30 – 15:30: NHS Main Plenary
15:30 – 16:30: UK Market Access, Procurement and NHS Supply Chain
Chair – Pete Phillips, Surgical Material Testing Laboratories, NWSSP
Discussion around the social value, UK resilience, decarbonisation and value based procurement. The session will aim to explain the various types of evidence and data that manufacturers may need to be able to win business with the Welsh NHS. It will cover test data, standard and regulatory compliance, NICE guidance, Health Technology Assessments (HTAs), and national initiatives such as the National Joint Registry.
Association British Healthcare Industries (ABHI) – Andrew Davies, Digital Health Lead
Procurement, NWSSP – Wyn Owens, Medical/Clinical Sourcing
Procurement, NWSSP Surgical Material Testing Laboratories – Dr James Evans, Research Manager
CEDAR, Cardiff &Vale Health Board – Rhys Morris, Director
17:00 – Close
